S&P/ASX All Ordinaries Index (ASX: XAO) shares are down 0.26% to 8,857.9 points on Thursday.
Among the 11 market sectors, financials are in the lead today, up 0.4%, as Commonwealth Bank of Australia (ASX: CBA) shares recover modestly from yesterday’s mammoth 10.3% drop.
The consumer staples sector is the laggard today, down 2.5%, after an explosive Federal Court judgement against Coles Group Ltd (ASX: COL).
ASX All Ords shares have slipped into the red for 2026, and are currently down 2% in the year to date (YTD).
But the experts say some stocks are on a vastly different path.
Here are four ASX All Ords shares with 12-month share price targets from the experts that suggest significant growth ahead.
Life360 Inc (ASX: 360)
The Life360 share price is $18.49, down 1.5% today.
Over the past six months, this ASX All Ords tech share has lost 50% of its market valuation.
The substantial decline came amid a broader tech sector rout that ran from late August to 30 March this year.
Since the turnaround began on 31 March, Life360 shares have risen 1.9%.
Life360 shares are vastly underperforming the S&P/ASX 200 Info Tech Index (ASX: XIJ), which is 12.5% higher since 31 March.
Bell Potter is optimistic on Life360 shares and gives the stock a buy rating.
The broker’s 12-month price target is $32.50, suggesting 76% upside from here.
Helloworld Travel Ltd (ASX: HLO)
Helloworld Travel shares are down 1.4% to $1.43 apiece, and down 25% YTD.
Shaw and Partners has a buy rating on this ASX All Ords travel share with a 12-month target of $2.80.
This implies 95% capital growth ahead.
Neuren Pharmaceuticals Ltd (ASX: NEU)
The Neuren Pharmaceuticals share price is $12.74, up 0.2% on Thursday.
This ASX All Ords healthcare share has fallen 33% in 2026 so far amid a broader sector downfall.
The S&P/ASX 200 Health Care Index (ASX: XHJ) is also down 33% YTD as the industry battles many headwinds.
However, Bell Potter is confident that Neuren Pharmaceuticals shares will come back.
The broker has renewed its buy rating with a price target of $22.
This implies 73% capital growth over the next 12 months.
Light & Wonder Inc (ASX: LNW)
The Light & Wonder share price is $113.86, down 1.6% today and down 27% YTD.
Bell Potter recently reiterated its buy rating on Light & Wonder shares but lowered its price target from $220 to $190.
This still implies impressive potential growth of 67% ahead for the ASX All Ords gaming share.
The post 4 ASX All Ords shares expected to rise 65% to 95% in a year appeared first on The Motley Fool Australia.
Should you invest $1,000 in Life360 right now?
Before you buy Life360 shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Buy, hold, sell: CBA, Life360, and Macquarie shares
- Down 42% this year, is it time to jump into Life360 shares?
- Here are the top 10 ASX 200 shares today
- Top brokers name 3 ASX shares to buy now
- Life360 shares rebound 4.5% today: Buy, sell or hold?
Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Light & Wonder Inc. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.